Market Overview

UPDATE: Bank of America Upgrades Bruker Corporation to Neutral on Improving Fundamentals

Share:
Related BRKR
Bruker Introduces MALDI Tissuetyper Solution With New High Speed RapifleX MALDI-TOF MS System For Anatomical Pathology Research
Otonomy, Renren And Other Names To Watch Heading Into Next Week

Bank of America upgraded Bruker Corporation (NASDAQ: BRKR) from Underperform to Neutral and raised the price objective from $15.00 to $19.50.

Bank of America noted, "Although we've been positive on BRKR's technology and long-term outlook, we've been cautious on shares chiefly due to the disappointing track record when it came to delivering on margin expansion, cash flow improvements, and profitability targets. While significant work remains, we are encouraged by the recent restructuring initiatives, which include hiring a new CFO and naming new operating group presidents. In addition, mgmt has shown a new willingness to reduce certain investments and prune unprofitable businesses, highlighting a renewed focus on not just growing, but growing profitably."

Bruker Corporation closed at $18.09 on Wednesday.

Latest Ratings for BRKR

DateFirmActionFromTo
Aug 2015Cantor FitzgeraldInitiates Coverage onHold
May 2015William BlairDowngradesOutperformMarket Perform
May 2015Mizuho SecuritiesDowngradesBuyNeutral

View More Analyst Ratings for BRKR
View the Latest Analyst Ratings

Posted-In: Bank of AmericaAnalyst Color Upgrades Analyst Ratings

 

Related Articles (BRKR)

Get Benzinga's Newsletters